QQ客服 官方微博 反馈留言

	A high-performance liquid chromatography-tandem mass spectrometry method for the determination of lifrafenib, a novel RAF kinase and EGFR inhibitor, in human plasma and urine and its application in clinical pharmacokinetic study
	Yao, Xueting; Song, Ling; Liu, Yang; Wang, Huanhuan; Liu, Jie; Jiang, Ji; Liu, Dongyang; Hu, Pei
	2019
卷号	166页码:20-29
关键词	HPLC-MS/MS Pharmacokinetics BRAF V600E EGFR Lifirafenib
ISSN号	0731-7085
DOI	10.1016/j.jpba.2018.12.038
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6345474
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Yao, Xueting,Song, Ling,Liu, Yang,et al. A high-performance liquid chromatography-tandem mass spectrometry method for the determination of lifrafenib, a novel RAF kinase and EGFR inhibitor, in human plasma and urine and its application in clinical pharmacokinetic study[J],2019,166:20-29.
APA	Yao, Xueting.,Song, Ling.,Liu, Yang.,Wang, Huanhuan.,Liu, Jie.,...&Hu, Pei.(2019).A high-performance liquid chromatography-tandem mass spectrometry method for the determination of lifrafenib, a novel RAF kinase and EGFR inhibitor, in human plasma and urine and its application in clinical pharmacokinetic study.,166,20-29.
MLA	Yao, Xueting,et al."A high-performance liquid chromatography-tandem mass spectrometry method for the determination of lifrafenib, a novel RAF kinase and EGFR inhibitor, in human plasma and urine and its application in clinical pharmacokinetic study".166(2019):20-29.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。